Literature DB >> 1979510

The effectiveness of alpha 2-adrenoceptor activation increases from the distal to the proximal part of the veins of canine limbs.

S Guimaraes1, J P Nunes.   

Abstract

1. The effectiveness of alpha 1- and alpha 2-adrenoceptor activation was compared at different levels of the saphenous and cephalic vein of the dog in vitro. 2. Helically cut strips were used to determine concentration-response curves to phenylephrine, noradrenaline, UK-14,304 (5-bromo-6-(imidazoline-2-ylamino)-quinoxaline) and B-HT 920 (2-amino-6-allyl-5,6,7,8-tetra-hydro-4H-(thiazo)-4,5-d-azepine). The effect of prazosin and yohimbine on these curves was also studied. 3. At the distal level, the maximum response to UK-14,304 amounted to 33 and 50% of those to noradrenaline in the saphenous and cephalic vein, respectively, while at the proximal level the maximum response to UK-14,304 amounted to 72 and 78% of those to noradrenaline, in the saphenous and cephalic vein, respectively. 4. In both vessels, the results obtained with B-HT 920 were very similar to those for UK-14,304. 5. The pD2 values for UK-14,304 - which were identical at the three levels of both vessels - and the pA2 values for the antagonism exerted by either prazosin or yohimbine against the responses to UK-14,304 indicate that the alpha 2-adrenoceptors are identical at the different levels of both vessels. 6. These results show that the effectiveness of alpha 2-adrenoceptor stimulation increases from the distal to the proximal regions of canine limb veins. Apparently, this is due to a greater density of alpha 2-adrenoceptors in the proximal regions. 7. Yohimbine is much more potent against phenylephrine distally than proximally in both vessels. However, after 30 nm phenoxybenzamine - a concentration which eliminates the vast majority of alpha,-adrenoceptors without affecting alpha 2-adrenoceptors - yohimbine became equally potent at both levels, suggesting that the difference existing before phenoxybenzamine depended on alpha,-adrenoceptors. Hence it is concluded that alpha,-adrenoceptors in distal and proximal portions may differ.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1979510      PMCID: PMC1917708          DOI: 10.1111/j.1476-5381.1990.tb12719.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  33 in total

1.  Cumulative dose-response curves. II. Technique for the making of dose-response curves in isolated organs and the evaluation of drug parameters.

Authors:  J M VAN ROSSUM
Journal:  Arch Int Pharmacodyn Ther       Date:  1963

2.  The effects of the 2-amino-tetrahydronaphthalene derivative M7, a selective alpha 2-adrenoceptor agonist in vitro.

Authors:  N B Shepperson; S Z Langer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-12       Impact factor: 3.000

3.  Heterogeneity of postsynaptic Alpha adrenergic receptors in mammalian aortas.

Authors:  R R Ruffolo; J E Waddell; E L Yaden
Journal:  J Pharmacol Exp Ther       Date:  1982-05       Impact factor: 4.030

4.  Functional postsynaptic alpha 2- but not alpha 1-adrenoceptors in dog saphenous vein exposed to phenoxybenzamine.

Authors:  J W Constantine; W Lebel; R Archer
Journal:  Eur J Pharmacol       Date:  1982-12-03       Impact factor: 4.432

5.  Pharmacological differentiation of postsynaptic alpha adrenoceptors in the dog saphenous vein.

Authors:  P J Fowler; M Grous; W Price; W D Matthews
Journal:  J Pharmacol Exp Ther       Date:  1984-06       Impact factor: 4.030

6.  Possible relationship between receptor reserve and the differential antagonism of alpha-1 and alpha-2 adrenoceptor-mediated pressor responses by calcium channel antagonists in the pithed rat.

Authors:  R R Ruffolo; E L Morgan; K Messick
Journal:  J Pharmacol Exp Ther       Date:  1984-09       Impact factor: 4.030

7.  A regional difference in the distribution of postsynaptic alpha-adrenoceptor subtypes in canine veins.

Authors:  T Shoji; H Tsuru; T Shigei
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-12       Impact factor: 3.000

8.  alpha 1- and alpha 2-Adrenoceptor-mediated pressor and chronotropic effects in the rat and rabbit.

Authors:  J C McGrath; N A Flavahan; C E McKean
Journal:  J Cardiovasc Pharmacol       Date:  1982       Impact factor: 3.105

9.  Types and functions of peripheral alpha-adrenoceptors.

Authors:  K Starke; J R Docherty
Journal:  J Cardiovasc Pharmacol       Date:  1982       Impact factor: 3.105

10.  Pharmacological characterization of alpha-adrenoreceptor subtypes in rat isolated thoracic aorta.

Authors:  A T Hamed; T D Johnson; K G Charlton; D E Clarke
Journal:  J Auton Pharmacol       Date:  1983-12
View more
  4 in total

1.  alpha(2)-adrenoceptor antagonist properties of OPC-28326, a novel selective peripheral vasodilator.

Authors:  K Orito; M Kishi; T Imaizumi; T Nakazawa; A Hashimoto; T Mori; T Kambe
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

2.  Involvement of alpha 1- and alpha 2-adrenoceptors in the responses of proximal and distal segments of the canine saphenous vein to exogenous and endogenous noradrenaline.

Authors:  O Pereira; D Moura; P Nunes; M J Vaz-da Silva; S Guimarães
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-06       Impact factor: 3.000

3.  Chloroethylclonidine irreversibly activates postjunctional alpha 2-adrenoceptors in the dog saphenous vein.

Authors:  J P Nunes; S Guimarães
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-09       Impact factor: 3.000

4.  The effectiveness of beta-adrenoceptor stimulation and the contribution of beta 1-adrenoceptors increase from the proximal to the distal part of the canine saphenous vein.

Authors:  S Guimarães; A Mota; R Begonha
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-06       Impact factor: 3.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.